These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Mishra SR, Chander Sharma B, Kumar A, Sarin SK. Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457 [Abstract] [Full Text] [Related]
47. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale. Merkel C, Gatta A, Donada C, Enzo E, Marin R, Amodio P, Torboli P, Angeli P, Cavallarin G, Sebastianelli G. Hepatology; 1995 Sep; 22(3):808-13. PubMed ID: 7657286 [Abstract] [Full Text] [Related]
49. Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis. Kong DR, Ma C, Wang M, Wang JG, Chen C, Zhang L, Hao JH, Li P, Xu JM. World J Gastroenterol; 2013 Jul 14; 19(26):4228-33. PubMed ID: 23864788 [Abstract] [Full Text] [Related]
50. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis. Bolognesi M, Sacerdoti D, Merkel C, Caregaro L, Bellon S, Gatta A. Bildgebung; 1995 Jun 14; 62(2):138-43. PubMed ID: 7663138 [Abstract] [Full Text] [Related]
56. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP. Hepatology; 2000 Jun 14; 31(6):1239-45. PubMed ID: 10827148 [Abstract] [Full Text] [Related]
57. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Albillos A, Bañares R, González M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM. Am J Gastroenterol; 2007 May 14; 102(5):1116-26. PubMed ID: 17391317 [Abstract] [Full Text] [Related]
58. Clinical vs haemodynamic response to drugs in portal hypertension. McCormick PA, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs AK. J Hepatol; 1998 Jun 14; 28(6):1015-9. PubMed ID: 9672178 [Abstract] [Full Text] [Related]
60. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis. Li T, Ke W, Sun P, Chen X, Belgaumkar A, Huang Y, Xian W, Li J, Zheng Q. BMJ Open; 2016 May 04; 6(5):e010902. PubMed ID: 27147389 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]